Enjoy complimentary customisation on priority with our Enterprise License!
The toxicology testing market size is forecast to increase by USD 32.58 billion at a CAGR of 15.61% between 2023 and 2028. The market is experiencing significant growth, driven by the high regulatory compliance in various industries, particularly in the food sector, and advances in toxicology testing technology. Digital platforms and telemedicine are emerging trends in the market, enabling remote sample collection and analysis. However, the lack of skilled professionals in toxicology testing services poses a challenge, necessitating the expansion of testing facilities and laboratories. Biological samples, such as urine, blood, saliva, and hair, are commonly used for toxicology testing to identify drugs and their metabolites. Regulatory adjustments and policy shifts are crucial factors influencing market growth, with stringent safety measures ensuring accurate and reliable testing results.
The market is a critical segment in the pharmaceutical and biotechnology industries, focusing on preclinical evaluation of drugs to ensure safety and efficacy. Combinatorial chemistry and high-throughput screening are key techniques used to identify potential toxins and determine pharmacokinetic profiles and ADME properties. Predictive toxicology, utilizing in vitro and computational models, is gaining popularity to minimize animal testing, addressing ethical concerns and public sentiment towards animal rights. Technological advancements in toxicology drug testing include the use of microdosing, organ-on-chip models, and artificial intelligence. Pharmaceutical and biotechnology companies prioritize toxicology testing for mental health, substance use issues, and healthcare priorities. Testing patterns continue to evolve, with comprehensive drug testing becoming increasingly common. Regulatory compliance and stringent quality standards remain crucial factors in the market's growth.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The pharmaceutical industry segment is estimated to witness significant growth during the forecast period. Toxicology testing plays a crucial role in the pharmaceutical industry, ensuring the safety and efficacy of drugs and biologics before they reach the market. This process involves assessing the biological effects of drugs and chemical agents on living organisms. Compliance with regulatory guidelines, such as those set by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), is mandatory. These regulations require extensive preclinical testing to evaluate drug safety and toxicity. With the advancement of technology, toxicology testing is increasingly being conducted using telemedicine and digital platforms. Sample collection and analysis can be done remotely, reducing the need for physical presence at laboratories and testing facilities.
Biological samples, including urine, blood, saliva, and hair, are used to detect drugs and their metabolites. Regulatory adjustments and policy shifts towards digital solutions are driving the growth of the market. Safety measures remain a top priority, ensuring accurate and reliable testing results.
Get a glance at the market share of various segments Request Free Sample
The pharmaceutical industry segment was valued at USD 5.92 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
Toxicology testing is a critical aspect of workplace safety and healthcare, involving the analysis of biological samples such as urine, blood, saliva, and hair to detect drugs and their metabolites. With the advent of telemedicine and digital platforms, toxicology testing is undergoing significant changes. Regulatory adjustments and policy shifts are enabling remote sample collection and analysis, ensuring continued safety measures during the COVID-19 pandemic. Laboratories and testing facilities are adapting to these changes, implementing advanced technologies for accurate and efficient testing. The market for toxicology testing is expected to grow, driven by the increasing demand for drug screening in various industries and the need for early detection and treatment of substance abuse. The use of digital platforms and telemedicine services will further expand the reach and accessibility of toxicology testing, making it an essential component of healthcare and workplace safety.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
High regulatory compliance in food industry is the key driver of the market. Toxicology testing plays a crucial role in various industries, particularly in pharmaceuticals and biotechnology, to ensure the safety and efficacy of drugs and substances. With the rise in demand for comprehensive drug testing and increasing healthcare priorities on mental health and substance use issues, the market for toxicology testing is experiencing significant growth. Technological advancements, such as toxicogenomics, high-throughput screening, remote testing, and rapid testing, are transforming the toxicology testing landscape. Toxicogenomics, for instance, allows for the identification and measurement of genetic responses to toxins, providing valuable information for risk assessment and drug development. Cell culture techniques enable the testing of potential toxins on living cells, providing more accurate and reliable results.
Moreover, regulatory compliance is essential in the food industry to prevent contamination and adulteration, and toxicology testing is a critical component of ensuring food safety. Pharmaceutical and biotechnology companies rely on toxicology testing to comply with regulatory requirements and protect public health. The healthcare landscape is continually evolving, and toxicology testing is an essential tool in addressing the challenges of the modern healthcare system.
Advances in toxicology testing technology is the upcoming trend in the market. The market is witnessing significant advancements driven by the adoption of innovative technologies such as toxicogenomics, high-throughput screening, and cell culture. Toxicogenomics, a branch of toxicology that uses genomic information to understand the toxic effects of chemicals, is gaining popularity due to its ability to detect diseases at a molecular level. In the pharmaceutical industry, there is a rising demand for comprehensive drug testing to identify specific biological functionalities with minimal adverse effects. This has led to the evolution of in-vitro testing methods, which involve experimentation on non-living systems, as opposed to the ineffective and often ethically controversial in-vivo methods.
Technological advancements in cell culture technologies, cellular imaging technologies, and other related fields are fueling the growth of the in-vitro testing market. Furthermore, the increasing focus on mental health and substance use issues in the healthcare landscape is driving the need for rapid and remote toxicology testing to ensure accurate and timely diagnosis. Biotechnology companies are at the forefront of these developments, investing heavily in research and development to bring new and innovative toxicology testing solutions to market.
The lack of skilled professionals in toxicology testing services is a key challenge affecting the market growth. Toxicology testing, a critical component of biopharmaceutical research and development, is experiencing a significant rise in demand due to the increasing focus on healthcare priorities, including mental health and substance use issues. Toxicogenomics, a branch of toxicology that uses genomic information to understand the toxic effects of chemicals, is driving technological advancements in this field. High-throughput screening techniques and cell culture models are being employed to improve the efficiency and accuracy of toxicology drug testing. Biotechnology and pharmaceutical companies are investing heavily in comprehensive drug testing to ensure the safety and efficacy of new drugs. The healthcare landscape is shifting towards remote and rapid testing solutions to reduce wait times and improve accessibility.
However, a major challenge in this field is the shortage of skilled toxicologists. The complex nature of toxicology testing requires specialized knowledge and expertise, which can only be gained through formal education, training, and operational experience. Despite this, the demand for toxicology testing is expected to continue growing as the importance of ensuring drug safety and efficacy becomes increasingly recognized.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abbott Laboratories - The company offers toxicology testing solutions such as iCup Drug Screen, which is an all-inclusive, on site urine drug screening device. The device simplifies the collection process and tests for up to 17 drugs.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is witnessing a significant rise in demand due to the increasing focus on ensuring safety and quality in various industries, including pharmaceuticals, biotechnology, food, and chemical. Preclinical evaluation of drugs involves determining their adme properties, pharmacokinetic profiles, and toxicological effects using combinatorial chemistry, high-throughput screening, cellular assays, biochemical assays, and molecular toxicology assays. Technological advancements in toxicology drug testing include the use of in silico models, ex vivo models, and in vitro models, such as Physiomimix and hepatosite in-vitro model. The healthcare landscape is evolving, with a growing emphasis on personalized medicine, precision toxicology, and rapid testing.
Moreover, consumer care companies, academic & research institutes, instrument & reagent suppliers, technology providers, regulatory authorities, and collaborative networks are key stakeholders in the market. The market is also driven by regulatory adjustments and policy shifts, such as the increasing use of remote testing and digital platforms for sample collection and analysis. Biological samples, including urine, blood, saliva, and hair, are used for toxicology testing to detect drugs and metabolites. Toxicology testing is an essential tool for workplace safety, forensic investigations, sports, addiction treatment, pharmaceutical research, and manufacturing quality check products. Regulatory-approved therapies and product recalls further the importance of toxicology testing in ensuring safety and compliance. The diagnostics segment, including safety pharmacology and ADME testing, is a significant contributor to the market's growth.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
178 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 15.61% |
|
Market growth 2024-2028 |
USD 32.58 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
15.18 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 43% |
|
Key countries |
US, Canada, UK, Germany, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Danaher Corp., BioIVT LLC, Bio Rad Laboratories Inc., Catalent Inc., CompuDrug Ltd., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, LABORATORY CORPORATION OF AMERICA HOLDINGS, Merck KGaA, PerkinElmer Inc, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., SGS SA, Aragen Life Sciences Pvt. Ltd., BICO Group AB, Ingenza Ltd, and Randox Laboratories Ltd. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
